Bone disease and aluminum: pathogenic considerations.

Bone disease and aluminum: pathogenic considerations.

Item
http://www.wikidata.org/entity/Q39833638
Effect of lanthanum carbonate and calcium acetate in the treatment of hyperphosphatemia in patients of chronic kidney disease.Bone health and vascular calcification relationships in chronic kidney disease.Accumulation of metals and minerals from phosphate binders.The safety of phosphate binders.Transferrin enhances the antiproliferative effect of aluminum on osteoblast-like cells.Phosphorus management in end-stage renal disease.Novel Fluorometric Turn On Detection of Aluminum by Chalcone-Based Chemosensor in Aqueous Phase.Lanthanum-Induced Mucosal Alterations in the Stomach (Lanthanum Gastropathy): a Comparative Study Using an Animal Model.Aluminum Trichloride Inhibited Osteoblastic Proliferation and Downregulated the Wnt/β-Catenin Pathway.Environmental effects of aluminium.Evolution of bone and plasma concentration of lanthanum in dialysis patients before, during 1 year of treatment with lanthanum carbonate and after 2 years of follow-up
P2860

Bone disease and aluminum: pathogenic considerations.

Item
http://www.wikidata.org/entity/Q39833638
description
1985 nî lūn-bûn
@nan
1985年の論文
@ja
1985年学术文章
@wuu
1985年学术文章
@zh-cn
1985年学术文章
@zh-hans
1985年学术文章
@zh-my
1985年学术文章
@zh-sg
1985年學術文章
@yue
1985年學術文章
@zh
1985年學術文章
@zh-hant
name
Bone disease and aluminum: pathogenic considerations.
@en
Bone disease and aluminum: pathogenic considerations.
@nl
type
label
Bone disease and aluminum: pathogenic considerations.
@en
Bone disease and aluminum: pathogenic considerations.
@nl
prefLabel
Bone disease and aluminum: pathogenic considerations.
@en
Bone disease and aluminum: pathogenic considerations.
@nl
P1433
P1476
P2093
P304
P31
P356
P433
P478
P577
P698
P921
P356
P1433
P1476
Bone disease and aluminum: pathogenic considerations.
@en
P2093
P304
P31
P356
10.1016/S0272-6386(85)80089-5
P433
P478
P577
P698
P921